Despite poor growth, the company's high P/E indicates investor hope for a business turnaround. However, high P/E and negative growth could disappoint shareholders. The company's high P/E and shrinking medium-term earnings are concerning, suggesting overpricing given recent conditions.
均瑶健康股票讨论区
暂无评论